The University of Queensland’s commercial arm UniQuest has entered into a licence agreement with Canadian health and wellness company PreveCeutical Medical, granting rights to its Sol-Gel technology for the delivery of cannabinoids. 

Dr Harendra Parekh and his team

The arrangement grants PreveCeutical the right to use the technology, developed at UQ’s School of Pharmacy by Dr Harendra Parekh and his team, to specifically deliver cannabinoids to all regions and membranes of the body, including intranasally. It also includes a licence to IP rights covered by a patent application.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Join or login
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Vel turpis nunc eget lorem dolor sed. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh. Nisl nunc mi ipsum faucibus vitae.
Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Sit amet consectetur adipiscing elit duis tristique sollicitudin nibh.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Avatar photo

Hannah Adler

hannah@cannabiz.com.au

Hannah is a communications professional and early-career researcher in the disciplines of health communication and health sociology. She is a PhD student at Griffith University currently writing a...

Leave a comment